These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36589880)

  • 41. CoRe: a robustly benchmarked R package for identifying core-fitness genes in genome-wide pooled CRISPR-Cas9 screens.
    Vinceti A; Karakoc E; Pacini C; Perron U; De Lucia RR; Garnett MJ; Iorio F
    BMC Genomics; 2021 Nov; 22(1):828. PubMed ID: 34789150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-Throughput Microfluidic Sorting of Live Magnetotactic Bacteria.
    Tay A; Pfeiffer D; Rowe K; Tannenbaum A; Popp F; Strangeway R; Schüler D; Di Carlo D
    Appl Environ Microbiol; 2018 Sep; 84(17):. PubMed ID: 29959254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluorescence imaging-based forward genetic screens to identify trafficking regulators in plants.
    Zwiewka M; Friml J
    Front Plant Sci; 2012; 3():97. PubMed ID: 22654887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Droplet-based microfluidic high-throughput screening of heterologous enzymes secreted by the yeast Yarrowia lipolytica.
    Beneyton T; Thomas S; Griffiths AD; Nicaud JM; Drevelle A; Rossignol T
    Microb Cell Fact; 2017 Jan; 16(1):18. PubMed ID: 28143479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced gene templates for supervised analysis of scale-limited CRISPR-Cas9 fitness screens.
    Vinceti A; Perron U; Trastulla L; Iorio F
    Cell Rep; 2022 Jul; 40(4):111145. PubMed ID: 35905712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
    Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
    J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New Method for Genome-Scale Functional Genomic Study in Bacteria with Superior Performance: CRISPR Interference Screen.
    Liao X; Xing XH; Zhang C
    Methods Mol Biol; 2022; 2377():123-141. PubMed ID: 34709614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identifying synthetic lethal targets using CRISPR/Cas9 system.
    Dhanjal JK; Radhakrishnan N; Sundar D
    Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultrathroughput immunomagnetic cell sorting platform.
    Philpott DN; Chen K; Atwal RS; Li D; Christie J; Sargent EH; Kelley SO
    Lab Chip; 2022 Dec; 22(24):4822-4830. PubMed ID: 36382608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A genome-wide CRISPR library for high-throughput genetic screening in Drosophila cells.
    Bassett AR; Kong L; Liu JL
    J Genet Genomics; 2015 Jun; 42(6):301-9. PubMed ID: 26165496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization.
    Escobar D; Bushara O; Sun L; Liao J; Yang GY
    Hum Pathol; 2022 Jan; 119():51-58. PubMed ID: 34717891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of functional regulatory elements in the human genome using pooled CRISPR screens.
    Borys SM; Younger ST
    BMC Genomics; 2020 Jan; 21(1):107. PubMed ID: 32005150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR/Cas9-Based Positive Screens for Cancer-Related Traits.
    Slipek NJ; Varshney J; Largaespada DA
    Methods Mol Biol; 2019; 1907():137-144. PubMed ID: 30542997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of Drug Resistance Genes Using a Pooled Lentiviral CRISPR/Cas9 Screening Approach.
    Kerek EM; Cromwell CR; Hubbard BP
    Methods Mol Biol; 2021; 2381():227-242. PubMed ID: 34590280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of a germline mutation in the APC gene on β-catenin in human embryonic stem cells.
    Yedid N; Kalma Y; Malcov M; Amit A; Kariv R; Caspi M; Rosin-Arbesfeld R; Ben-Yosef D
    BMC Cancer; 2016 Dec; 16(1):952. PubMed ID: 28010732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-throughput genetic screens using CRISPR-Cas9 system.
    Kweon J; Kim Y
    Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic balance in colorectal cancer is maintained by optimal Wnt signaling levels.
    Imkeller K; Ambrosi G; Klemm N; Claveras Cabezudo A; Henkel L; Huber W; Boutros M
    Mol Syst Biol; 2022 Aug; 18(8):e10874. PubMed ID: 35904277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Next-Generation Sequencing of Genome-Wide CRISPR Screens.
    Yau EH; Rana TM
    Methods Mol Biol; 2018; 1712():203-216. PubMed ID: 29224076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guide Swap enables genome-scale pooled CRISPR-Cas9 screening in human primary cells.
    Ting PY; Parker AE; Lee JS; Trussell C; Sharif O; Luna F; Federe G; Barnes SW; Walker JR; Vance J; Gao MY; Klock HE; Clarkson S; Russ C; Miraglia LJ; Cooke MP; Boitano AE; McNamara P; Lamb J; Schmedt C; Snead JL
    Nat Methods; 2018 Nov; 15(11):941-946. PubMed ID: 30297964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An engineered transcriptional reporter of protein localization identifies regulators of mitochondrial and ER membrane protein trafficking in high-throughput CRISPRi screens.
    Coukos R; Yao D; Sanchez MI; Strand ET; Olive ME; Udeshi ND; Weissman JS; Carr SA; Bassik MC; Ting AY
    Elife; 2021 Aug; 10():. PubMed ID: 34414886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.